CSIMarket
 


Scpharmaceuticals Inc   (SCPH)
Other Ticker:  
 

Scpharmaceuticals Inc 's Total Debt to Equity

SCPH's quarterly Total Debt to Equity and Total Debt, Equity growth




SCPH Total Debt to Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -50.71 % -41.4 % -34.59 % -31.28 % -29.73 %
Y / Y Total Debt Change -49.47 % -36.69 % -23.84 % -10.94 % 2 %
Total Debt to Equity MRQ 0.32 0.3 0.3 0.3 0.31
Overall Ranking # # # # #
Seq. Equity Change -23.1 % -18.09 % -12.53 % -10.52 % -8.59 %
Seq. Total Debt Change -19.77 % -16.45 % -14.1 % -12.25 % 0.54 %



Total Debt to Equity third quarter 2022 Comment
In Spite of the debt repayement of -19.77%, in III. Quarter ,Total Debt to Equity detoriated to 0.32, above company's average Total Debt to Equity.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved lowest Total Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. .

Explain Debt to Equity Ratio?
Where is SCPH most successful ?
Total Debt to Equity SCPH on the trailing twelve month basis
Total Debt to Equity third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Scpharmaceuticals Inc 's Equity $ 31 Millions Visit SCPH's Balance sheet
Scpharmaceuticals Inc 's Total Debt $ 10 Millions Visit SCPH's Balance sheet
Source of SCPH's Sales Visit SCPH's Sales by Geography


Cumulative Scpharmaceuticals Inc 's Total Debt to Equity

SCPH's Total Debt to Equity for the trailling 12 Months

SCPH Total Debt to Equity

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -50.71 % -41.4 % -34.59 % -31.28 % -29.73 %
Y / Y Total Debt TTM Growth -49.47 % -36.69 % -23.84 % -10.94 % 2 %
Total Debt to Equity TTM 0.3 0.3 0.3 0.29 0.27
Total Ranking TTM # 1216 # 1479 # 1579 # 1391 # 1141
Seq. Equity TTM Growth -23.1 % -18.09 % -12.53 % -10.52 % -8.59 %
Seq. Total Debt TTM Growth -19.77 % -16.45 % -14.1 % -12.25 % 0.54 %


TTM Total Debt to Equity Comment
On the trailing twelve months basis Due to debt repayement of -19.77% Scpharmaceuticals Inc has not changed Total Debt to Equity in the III. Quarter to 0.3, above Scpharmaceuticals Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 77 other companies have achieved lower Total Debt to Equity than Scpharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. 1216.

Explain Debt to Equity Ratio?
Where is SCPH most successful ?
Total Debt to Equity SCPH on the trailing twelve month basis

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 78
Healthcare Sector # 216
Within the Market # 1216


TTM Total Debt to Equity Statistics
High Average Low
0.22 0.08 0.01
(Sep 30 2022)   (Dec 31 2020)




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Total Debt to EquitySep 30 2022 MRQ Total DebtSep 30 2022 MRQ Equity
Marinus Pharmaceuticals Inc   0.86 $ 70.780  Millions$ 82.004  Millions
Innoviva Inc   0.84 $ 539.810  Millions$ 641.368  Millions
Spectrum Pharmaceuticals Inc   0.79 $ 28.488  Millions$ 35.852  Millions
Journey Medical Corporation  0.76 $ 19.810  Millions$ 26.184  Millions
Otonomy Inc   0.75 $ 16.130  Millions$ 21.397  Millions
Seres Therapeutics Inc   0.75 $ 50.857  Millions$ 67.585  Millions
Cryoport inc   0.73 $ 407.432  Millions$ 555.721  Millions
Allarity Therapeutics Inc   0.73 $ 1.057  Millions$ 1.447  Millions
Emergent Biosolutions Inc   0.73 $ 1,053.300  Millions$ 1,449.300  Millions
Arcutis Biotherapeutics Inc   0.73 $ 196.753  Millions$ 270.774  Millions
Bioxcel Therapeutics Inc   0.72 $ 91.695  Millions$ 126.986  Millions
Alaunos Therapeutics Inc   0.71 $ 22.668  Millions$ 32.113  Millions
Tg Therapeutics inc   0.70 $ 70.038  Millions$ 100.481  Millions
Merck and Co Inc   0.68 $ 30,418.000  Millions$ 44,524.000  Millions
Royalty Pharma Plc  0.68 $ 7,111.260  Millions$ 10,416.403  Millions
Opiant Pharmaceuticals Inc   0.67 $ 13.761  Millions$ 20.502  Millions
Ironwood Pharmaceuticals inc   0.67 $ 395.850  Millions$ 591.063  Millions
Maravai Lifesciences Holdings Inc   0.63 $ 528.264  Millions$ 841.669  Millions
Trevena inc   0.62 $ 13.533  Millions$ 21.863  Millions
Durect Corp  0.60 $ 21.034  Millions$ 34.854  Millions
Cingulate Inc   0.60 $ 5.000  Millions$ 8.367  Millions
Axsome Therapeutics Inc   0.60 $ 93.913  Millions$ 157.361  Millions
Vbi Vaccines Inc  0.58 $ 48.418  Millions$ 83.817  Millions
Tempest Therapeutics Inc   0.57 $ 15.336  Millions$ 26.773  Millions
Eton Pharmaceuticals Inc   0.57 $ 6.386  Millions$ 11.181  Millions
Harmony Biosciences Holdings inc   0.56 $ 191.725  Millions$ 343.884  Millions
Cerevel Therapeutics Holdings Inc   0.56 $ 335.006  Millions$ 603.362  Millions
Horizon Therapeutics Public Limited Company  0.51 $ 2,565.140  Millions$ 5,033.687  Millions
Aptinyx Inc   0.51 $ 24.709  Millions$ 48.792  Millions
Assertio Holdings inc   0.51 $ 68.157  Millions$ 134.915  Millions

Date modified: 2022-11-13T02:37:57+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RHE's Profile

Stock Price

RHE's Financials

Business Description

Fundamentals

Charts & Quotes

RHE's News

Suppliers

RHE's Competitors

Customers & Markets

Economic Indicators

RHE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071